Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

ROSEMONT, Ill., April 1, 2025 /PRNewswire/ -- The American Academy of Dermatology has announced the results of its annual election. The Academy's new officers and board members will lead the world ...

Hidradenitis suppurativa (HS) highlights from AAD 2025 include studies of HS patients' risk for cardiovascular disease or ...

From PRP injections to low-level laser therapy and stem cell therapy, stress-induced hair loss problems have new, ...

Ruxolitinib 1.5% cream significantly reduces pruritus and lesion severity among adults with prurigo nodularis for up to 12 weeks of treatment.

In this video, Peter Lio, MD, highlighted research from the American Academy of Dermatology meeting and said his biggest takeaway from the meeting was that dermatologists are in “the decade of atopic ...

In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from presentations at the American Academy of Dermatology meeting.

JAAD’s recognition affirms the groundbreaking nature of AVAVA’s approach. The study demonstrates how Focal Point Technology™ delivers energy at precise depths up to 2mm, allowing healthcare ...

The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted clinicians, academicians, allied health professionals, and others ...